|
|
|
Insider
Information: |
Kirk Randal J |
Relationship: |
10% Owner |
City: |
Radford |
State: |
VA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
3,684,697 |
|
Indirect Shares
|
67,796,291 |
|
|
Direct
Value |
$179,101,866 |
|
|
Indirect Value
|
$415,833,338 |
|
|
Total
Shares |
71,480,988 |
|
|
Total
Value |
$594,935,205 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
14
|
0
|
Stock
price went up :
|
7
|
0
|
Stock
price went down : |
7
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
48.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Clinical Data Inc |
CLDA |
Director, 10% Owner |
2011-04-12 |
0 |
2011-04-12 |
0 |
Premium* |
|
Halozyme Therapeutics Inc |
HALO |
10% Owner |
2018-08-28 |
3,562,388 |
2018-08-28 |
6,629,464 |
Premium* |
|
Precipio Inc |
PRPO |
10% Owner |
2012-02-03 |
0 |
2018-08-28 |
27,151 |
Premium* |
|
Precigen Inc |
PGEN |
|
|
0 |
2024-05-02 |
51,557,665 |
Premium* |
|
Alaunos Therapeutics |
TCRT |
Director, 10% Owner |
2015-12-31 |
122,309 |
2015-12-31 |
9,570,094 |
Premium* |
|
Aquabounty Technologies, Inc. |
AQB |
10% Owner |
2020-02-13 |
0 |
2020-12-17 |
11,917 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
271 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 10 of 11
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
HALO |
Halozyme Therapeutics Inc |
Director |
|
2007-09-17 |
4 |
B |
$8.66 |
$2,061,253 |
I/I |
238,020 |
3,931,426 |
2.25 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2018-06-29 |
4 |
S |
$16.97 |
$2,077,654 |
I/I |
(122,431) |
3,796,606 |
0 |
- |
|
PGEN |
Precigen Inc |
Chief Executive Officer |
|
2019-05-20 |
4 |
B |
$4.63 |
$2,095,084 |
I/I |
452,502 |
148,329 |
2.64 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2018-06-28 |
4 |
S |
$16.99 |
$2,181,261 |
I/I |
(128,385) |
3,869,359 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2012-05-17 |
4 |
B |
$7.50 |
$2,242,553 |
I/I |
299,007 |
3,977,445 |
2.25 |
- |
|
PGEN |
Precigen Inc |
Chief Executive Officer |
|
2017-08-11 |
4 |
B |
$18.85 |
$2,499,981 |
I/I |
132,625 |
6,782,622 |
2.64 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2012-05-16 |
4 |
B |
$7.44 |
$2,566,130 |
I/I |
344,910 |
3,678,438 |
2.25 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2018-08-08 |
4 |
S |
$17.52 |
$2,570,499 |
I/I |
(146,718) |
3,529,470 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2018-07-26 |
4 |
S |
$17.30 |
$2,595,000 |
I/I |
(150,000) |
3,645,729 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2018-08-21 |
4 |
S |
$17.15 |
$2,765,369 |
I/I |
(161,246) |
2,894,871 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2012-05-15 |
4 |
B |
$7.35 |
$3,142,720 |
I/I |
427,581 |
3,333,528 |
2.25 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2018-08-10 |
4 |
S |
$17.08 |
$3,466,540 |
I/I |
(202,959) |
3,276,273 |
0 |
- |
|
CLDA |
Clinical Data Inc |
Director |
|
2007-02-26 |
4 |
OE |
$19.45 |
$3,585,802 |
I/I |
184,360 |
193,343 |
0 |
- |
|
CLDA |
Clinical Data Inc |
Director |
|
2006-02-09 |
4 |
A |
$23.40 |
$3,588,507 |
I/I |
153,355 |
153,353 |
|
- |
|
PGEN |
Precigen Inc |
Executive Chairman |
|
2020-08-11 |
4 |
B |
$4.50 |
$3,638,331 |
I/I |
808,518 |
218,459 |
2.64 |
% |
|
PGEN |
Precigen Inc |
Chief Executive Officer |
|
2015-12-11 |
4 |
B |
$29.83 |
$3,715,801 |
I/I |
124,475 |
6,608,167 |
2.64 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2018-08-09 |
4 |
S |
$17.48 |
$3,900,260 |
I/I |
(223,127) |
3,396,879 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2008-06-23 |
4 |
B |
$5.58 |
$4,154,573 |
I/I |
713,232 |
1,271,423 |
2.25 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2011-08-09 |
4 |
B |
$5.88 |
$4,341,386 |
I/I |
738,331 |
738,331 |
2.25 |
- |
|
PRPO |
Precipio Inc |
10% Owner |
|
2016-01-06 |
4 |
B |
$1.00 |
$4,474,825 |
I/I |
4,474,825 |
894,613 |
1.5 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2018-08-23 |
4 |
S |
$18.48 |
$4,644,671 |
I/I |
(251,335) |
2,280,894 |
0 |
- |
|
PGEN |
Precigen Inc |
Chief Executive Officer |
|
2013-08-13 |
4 |
A |
$0.00 |
$4,788,448 |
I/I |
5,399,630 |
131,081 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
Director |
|
2008-03-19 |
4 |
B |
$5.80 |
$5,142,570 |
I/I |
886,650 |
5,064,196 |
2.25 |
- |
|
HALO |
Halozyme Therapeutics Inc |
10% Owner |
|
2018-08-14 |
4 |
S |
$17.36 |
$5,262,996 |
I/I |
(303,168) |
3,096,119 |
0 |
- |
|
PRPO |
Precipio Inc |
10% Owner |
|
2017-06-29 |
4 |
A |
$0.00 |
$5,289,450 |
I/I |
359,785 |
27,651 |
0 |
- |
|
271 Records found
|
|
Page 10 of 11 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|